New scanner could spot brain tumor types without a needle
NCT ID NCT06294418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of MRI-like scan called Field Cycling Imaging (FCI) on 9 people who had surgery for low-grade gliomas. The goal was to see if FCI can tell apart different subtypes of these slow-growing brain tumors without needing another surgery or biopsy. Each participant had one FCI scan, and researchers checked whether the scan's signals matched the known tumor type.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new, non-invasive way to identify glioma subtypes without needing a biopsy.
- What could go wrong
- This is a very small pilot study with only 9 participants, so results may not apply to everyone. The technique is still experimental and may not prove useful in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aberdeen Royal Infirmary
Aberdeen, AB25 2ZD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- Could a parasite drug fight childhood brain tumors?
- A new PET scan tracks brain tumors by their appetite for tryptophan
- Can a simple dye help surgeons see brain tumors in real time?